| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenues | 2,990.329 | 4,744.246 | 3,587.026 | 17,850.411 |
| Cost of revenues (including cost of revenues resulting from transactions with a related party of 31,328 and 56,523 for the three and six months ended june 30, 2025, respectively, and of 25,117 and 25,117 for the three and six months ended june 30, 2024, respectively) | - | 2,526.651 | 2,486.742 | - |
| Cost of revenues (including cost of revenues resulting from transactions with a related party of 61,078 and 117,601 for the three and nine months ended september 30, 2025, respectively, and of 101,452 and 126,569 for the three and nine months ended september 30, 2024, respectively) | 1,521.92 | - | - | 3,433.024 |
| Gross profit | 1,468.409 | 2,217.595 | 1,100.284 | 14,417.387 |
| Research and development expenses | 0 | 161.481 | 123.893 | 107.529 |
| Selling expenses | 94.718 | 385.622 | 291.16 | 243.11 |
| General and administrative expenses (including general and administrative expenses resulting from transactions with a related party of nil and 29,048 for the three and nine months ended september 30, 2025, respectively, and of 17,474 and 23,947 for the three and nine months ended september 30, 2024, respectively) | 1,384.838 | 1,563.027 | 1,929.388 | 1,966.717 |
| Total operating expenses | 1,479.556 | 2,110.13 | 2,344.441 | 2,317.356 |
| Income (loss) from continuing operations | -11.147 | 107.465 | -1,244.157 | 12,100.031 |
| Loss on sale of warrants | 0 | - | - | 3,970.628 |
| Changes in fair value of investments in marketable securities | 20.539 | - | - | 122.272 |
| Changes in fair value of investments in warrants | 146.769 | -124.281 | 51.621 | -2,869.407 |
| Changes in fair value of investments in marketable securities | - | 852.709 | -1,781.664 | - |
| Changes in fair value of derivative liability | 9.679 | - | - | - |
| Interest income | 1.046 | 1.841 | 3.02 | 10.933 |
| Interest expenses | 21.083 | 32.665 | 29.133 | 31.393 |
| Other income | 40.332 | 21.561 | 35.359 | 24.04 |
| Other expenses | 6.988 | 17.248 | 12.549 | 82.457 |
| Total other expenses | -122.602 | 950.479 | -1,836.588 | -1,057.826 |
| Income (loss) from continuing operations before income tax expense | -133.749 | 1,057.944 | -3,080.745 | 11,042.205 |
| Income tax expense | 3.373 | -3.562 | 56.636 | 225.275 |
| Net income (loss) from continuing operations | -137.122 | - | - | - |
| Income (loss) from discontinued operations, net of income tax | 488.297 | - | - | - |
| Net income (loss) | 351.175 | 1,061.506 | -3,137.381 | 10,816.93 |
| Less net loss attributable to non-controlling interests | -82.897 | -38.396 | -50.389 | -240.876 |
| Net income (loss) attributable to heartcore enterprises, inc | 434.072 | 1,099.902 | -3,086.992 | 11,057.806 |
| Dividends accrued on series a convertible preferred shares | 56.222 | 0.611 | - | - |
| Net income (loss) attributable to heartcore enterprises, inc. common shareholders | 377.85 | 1,099.291 | - | - |
| Basic | 0.02 | 0.05 | -0.14 | 0.53 |
| Basic | 23,310,770 | 22,088,909 | 22,054,029 | 20,864,144 |
| Diluted | 0.02 | 0.04 | -0.14 | 0.53 |
| Diluted | 28,155,306 | 27,079,975 | 22,054,029 | 20,864,144 |
HeartCore Enterprises, Inc. (HTCR)
HeartCore Enterprises, Inc. (HTCR)